A technician conducts research on the Covid-19 virus at the University of Hong Kong on March 20, 2020. Photo: Bloomberg
A technician conducts research on the Covid-19 virus at the University of Hong Kong on March 20, 2020. Photo: Bloomberg
Kenny Shui
Opinion

Opinion

The View by Kenny Shui and Arthur Tsang

How Hong Kong can build on its strengths to become a global biotech data hub

  • The city is a major financing centre for biotech; it must now cement its reputation as a research hub
  • It already has two key advantages: world-class universities and a wealth of clinical and medical data

A technician conducts research on the Covid-19 virus at the University of Hong Kong on March 20, 2020. Photo: Bloomberg
A technician conducts research on the Covid-19 virus at the University of Hong Kong on March 20, 2020. Photo: Bloomberg
READ FULL ARTICLE